Effect-site Concentration of Remifentanil for Smooth Removal of the Double-lumen Endotracheal Tube

PHASE4CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Remifentanil Concentration for Smooth Emergence
Interventions
DRUG

Remifentanil titration

Initial concentration being 1.5ng/ml for the first patient The smooth emergence was defined as extubation without cough-a strong and sudden contraction of the abdomen. The predetermined concentration was decreased by 0.5 ng/ml for the next patient if the patient did not cough during emergence and similarly, if the patient coughed anytime during emergence, it was considered failed smooth emergence and predetermined concentration was increased by 0.5 ng/ml.

Trial Locations (1)

443-380

Jiyoung Yoo, Suweon

All Listed Sponsors
lead

Ajou University School of Medicine

OTHER

NCT02528825 - Effect-site Concentration of Remifentanil for Smooth Removal of the Double-lumen Endotracheal Tube | Biotech Hunter | Biotech Hunter